Oral Metformin for Treatment of ABCA4 Retinopathy

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Oral Metformin for Treatment of ABCA4 Retinopathy	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Stargardt disease, eye disorder, hereditary disease, inherited retinal dystrophy, macular degeneration, retinal degeneration, retinal disorder	Active, not recruiting	Phase 1 / Phase 2	2026-09-24		NCT04545736

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Eye Institute (NEI)	122

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National Institutes of Health Clinical Center	Bethesda	United States	800
University of Michigan	Ann Arbor	United States	2

Clinical trials